Alaunos Therapeutics, Inc. filed its 10-K on Mar 07, 2023 for the period ending Dec 31, 2022. In this report its auditor, McGladrey LLP - RSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | -1.85% | -0.93% | -0.05% |
1st Jan change | Capi. | |
---|---|---|
-0.05% | 17.29M | |
+8.87% | 115B | |
+9.76% | 105B | |
-12.91% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.28% | 16.01B | |
+0.97% | 14.14B | |
+18.23% | 10.71B |
- Stock Market
- Equities
- TCRT Stock
- News Alaunos Therapeutics, Inc.
- Alaunos Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt